Get the app
public
ios_share
The Readout Loud
chevron_right
Episode 124: Pharma's lobbying dollars, Alnylam's future, and diversity in Covid-19 studies
Aug 13, 2020
26:48
forum
Ask episode
play_arrow
Play
view_agenda
Chapters
auto_awesome
Transcript
info_circle
Episode notes
Is pharma scared of Kamala Harris? Are there second acts in biotech? And why don't Covid-19 trials look more diverse?
The Readout Loud The Readout Loud The Readout Loud